Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Association of overexpression of hexokinase II with chemoresistance in epithelial ovarian cancer

Published:2013-08-15 Issue:3 Volume:14 Page:345-353
ISSN:1591-8890
Container-title:Clinical and Experimental Medicine
language:en
Short-container-title:Clin Exp Med

Author:

Suh Dong Hoon,Kim Min A.,Kim Haeryoung,Kim Mi-Kyung,Kim Hee Seung,Chung Hyun Hoon,Kim Yong-Beom,Song Yong Sang

Publisher

Springer Science and Business Media LLC

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10238-013-0250-9.pdf

Reference40 articles.

1. Szegezdi E, Cahill S, Meyer M, O’Dwyer M, Samali A (2006) TRAIL sensitisation by arsenic trioxide is caspase-8 dependent and involves modulation of death receptor components and Akt. Br J Cancer 94(3):398–406. doi: 10.1038/sj.bjc.6602954

2. Miller DS, Blessing JA, Krasner CN, Mannel RS, Hanjani P, Pearl ML, Waggoner SE, Boardman CH (2009) Phase II evaluation of pemetrexed in the treatment of recurrent or persistent platinum-resistant ovarian or primary peritoneal carcinoma: a study of the Gynecologic Oncology Group. J Clin Oncol 27(16):2686–2691. doi: 10.1200/JCO.2008.19.2963

3. Itamochi H (2010) Targeted therapies in epithelial ovarian cancer: molecular mechanisms of action. World J Biol Chem 1(7):209–220. doi: 10.4331/wjbc.v1.i7.209

4. Suh DH, Kim JW, Kim K, Kang SB (2010) Major clinical research advances in gynecologic cancer in 2010. J Gynecol Oncol 21(4):209–218. doi: 10.3802/jgo.2010.21.4.209

5. Suh DH, Kim MK, No JH, Chung HH, Song YS (2011) Metabolic approaches to overcoming chemoresistance in ovarian cancer. Ann N Y Acad Sci 1229:53–60. doi: 10.1111/j.1749-6632.2011.06095.x

Cited by 76 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hexokinase 2 as an independent risk factor for worse patient survival in esophageal adenocarcinoma and as a potential therapeutic target protein: A retrospective, single‑center cohort study;Oncology Letters;2024-08-13

2. Mechanism and rational combinations with GP‐2250, a novel oxathiazine derivative, in ovarian cancer;Cancer Medicine;2024-08

3. Diagnostic, prognostic, and therapeutic biomarkers of ovarian cancer;Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks;2024

4. Tumor microenvironment and chemoresistance;Peritoneal Tumor Microenvironment of Cancers on Cancer Hallmarks;2024

5. Targeting the Warburg effect: A revisited perspective from molecular mechanisms to traditional and innovative therapeutic strategies in cancer;Acta Pharmaceutica Sinica B;2023-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3